Publications

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19

Assmus F. et al, (2022), Microorganisms, 10, 1639 - 1639

George JA. et al, (2021), CLINICAL NUTRITION ESPEN, 42, 416 - 416

Adehin A. et al, (2020), Naunyn-Schmiedeberg's archives of pharmacology, 393, 1003 - 1011

Adepiti AO. et al, (2020), European journal of drug metabolism and pharmacokinetics, 45, 81 - 88

Adehin A. et al, (2020), Breast cancer (Dove Medical Press), 12, 123 - 130

Adepiti AO. et al, (2020), REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 30, 432 - 435

Bolaji OO. et al, (2019), Pharmacogenomics, 20, 915 - 926

Adehin A. et al, (2019), Drug metabolism and pharmacokinetics, 34, 194 - 200

Adehin A. et al, (2019), Current therapeutic research, clinical and experimental, 91, 1 - 4

Adehin A. et al, (2019), Leukemia & lymphoma, 60, 216 - 221

Adehin A. et al, (2019), Current therapeutic research, clinical and experimental, 91, 33 - 38

Anumu George J. et al, (2018), Clinical nutrition ESPEN, 27, 96 - 99

Edema O. et al, (2018), Journal of clinical pharmacology, 58, 1061 - 1066

Adehin A. and Bolaji OO., (2018), BMC research notes, 11

Adehin A. et al, (2017), Polish Annals of Medicine, 24, 144 - 147

Adehin A. et al, (2017), Drug metabolism and pharmacokinetics, 32, 189 - 191

Adehin A. et al, (2017), Drug metabolism and personalized therapy, 32, 39 - 47

Adehin A. and Bolaji OO., (2015), Drug metabolism and personalized therapy, 30, 203 - 210

Adehin A. and Bolaji OO., (2015), European journal of clinical pharmacology, 71, 687 - 690